Citation Impact
Citing Papers
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
2010
Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
2010
Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
2014 StandoutNobel
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
2008
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
2012
Estrogen receptor mutations and their role in breast cancer progression
2014
Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens
2009
Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo
2018 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
A view on drug resistance in cancer
2019 StandoutNature
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Diabetes mellitus and risk of breast cancer: A meta‐analysis
2007
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Obesity and cancer risk: the role of the insulin–IGF axis
2006
Cancer cachexia: Developing multimodal therapy for a multidimensional problem
2008
Coordinated regulation of myeloid cells by tumours
2012 Standout
Obesity and cancer: Pathophysiological and biological mechanisms
2008
Definition and classification of cancer cachexia: an international consensus
2011 Standout
The Cancer Genome Atlas Pan-Cancer analysis project
2013 Standout
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
2013
Lessons from the Drug Discovery of Lapatinib, a Dual ErbB1/2 Tyrosine Kinase Inhibitor
2006
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing
2008
Diabetes in Asia
2009 Standout
The GH/IGF-1 axis in ageing and longevity
2013
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
The emerging roles of forkhead box (Fox) proteins in cancer
2007
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
2007
Treatment for the endocrine resistant breast cancer: Current options and future perspectives
2017
Emerging Biological Principles of Metastasis
2017 Standout
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure
2010
An Updated Review on Cancer Risk Associated with Incretin Mimetics and Enhancers
2015
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
2017
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Eicosanoids and cancer
2010 Standout
Hedgehog beyond medulloblastoma and basal cell carcinoma
2010
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
2008 Standout
Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
2011
Inflammatory burden and amino acid metabolism in cancer cachexia
2008
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
2010
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
The PI3K Pathway in Human Disease
2017 Standout
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
2017
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
2012 Standout
Discovery and saturation analysis of cancer genes across 21 tumour types
2014 StandoutNature
Comprehensive identification of mutational cancer driver genes across 12 tumor types
2013
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
2006
The primary cilium: a signalling centre during vertebrate development
2010 Standout
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
2007
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Developmental signaling pathways in cancer stem cells of solid tumors
2012
Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
2009 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Offline assessment of atherosclerotic coronary calcium from electron beam tomograms.
1995
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
2010
Breast Cancer Treatment
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2− Metastatic Breast Cancer
2016
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia
2007
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
2016
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Proteome of Metastatic Canine Mammary Carcinomas: Similarities to and Differences from Human Breast Cancer
2010
The genesis and evolution of high-grade serous ovarian cancer
2010
Honokiol: A Review of Its Anticancer Potential and Mechanisms
2019
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
2015
Histone H3K27ac separates active from poised enhancers and predicts developmental state
2010 Standout
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
2007
Works of Ido Wolf being referenced
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells
2011
Diabetes mellitus and breast cancer
2005
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
2006
Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer
2007
BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27Kip1
2005
FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer
2006
High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer
2008
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
2006
Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer
2008
Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion
2016
The mitogen-activated protein kinase signaling cascade: from bench to bedside.
2002
15-Hydroxyprostaglandin Dehydrogenase Is a Tumor Suppressor of Human Breast Cancer
2006
Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest
2007
Nonsteroidal Anti-inflammatory Drugs Suppress Glioma via 15-Hydroxyprostaglandin Dehydrogenase
2008
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
2013